JORVEZA is a prescription medication specifically designed for the treatment of eosinophilic esophagitis (EoE), a chronic immune system disease that affects the esophagus. The active ingredient in JORVEZA is budesonide, a corticosteroid that works by reducing inflammation and suppressing the immune response in the esophagus. This helps alleviate symptoms associated with EoE, such as difficulty swallowing, food getting stuck in the esophagus, and chest pain. JORVEZA is formulated as an orodispersible tablet, meaning it dissolves quickly in the mouth, making it easier for patients to take. It is the first medication specifically approved for the treatment of eosinophilic esophagitis, marking a significant advancement in the management of this condition.